Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation

European Journal of Pharmacology

Volumn 362, Issue 1, 1998, Pages 1-8

  Kaplan, Gary B ^a   Coyle, Tara Sharon ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Adenosine; Morphine; Mouse; Opiate dependence; Opiate withdrawal; Purinergic receptor

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 5' AMINO 5' DEOXYADENOSINE; ADENOSINE; ADENOSINE KINASE INHIBITOR; IODOTUBERICIDIN; MORPHINE; NALOXONE; OPIATE; PHOSPHODIESTERASE INHIBITOR; PURINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIARRHEA; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREMOR; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ADENOSINE KINASE; ANIMALS; BODY WEIGHT; CAFFEINE; DEOXYADENOSINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICE; MORPHINE; RECEPTORS, PURINERGIC P1; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032423128     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00724-9     Document Type: Article

References (39)

1. Acquas, E., DiChiara, G., 1992. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58, 1620-1625.
2. Ahlijanian, M.K., Takemori, A.E., 1986. Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice. J. Pharmacol. Exp. Ther. 236, 615-620.
3. Bonci, A., Williams, J.T., 1996. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16, 631-639.
4. Britton, D.R., Mikusa, J., Lee, L., Williams, M., Kowaluk, E., 1996. Adenosine kinase inhibition enhances kainic acid-induced increases in striatal adenosine. Soc. Neurosci. Abstr. 21, 1568.
5. Brundege, J.M., Diao, L., Proctor, W.R., Dunwiddie, T.V., 1997. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacol. 36, 1201-1210.
6. 1 receptor agonist, suppresses ethanol withdrawal syndrome in rats. Alcohol and Alcoholism 29, 261-264.
7. Contreras, A., Germany, A., Villar, M., 1990. Effects of some adenosine analogs on morphine-induced analgesia and tolerance. Gen. Pharmacol. 21, 763-767.
8. Daly, J.W., 1993. Mechanism of action of caffeine. In: Garattini, S. (Ed.), Caffeine, Coffee, and Health. Raven Press, New York, pp. 97-150.
9. Diana, M., Pistis, M., Muntoni, A., Gessa, G., 1995. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272, 781-785.
10. Dionyssopoulos, T., Hope, W., Coupar, I.M., 1992. Effect of adensoine analogues on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 42, 201-206.
11. Germany, A., Contreras, E., 1994. Purinergic drugs and calcium channel antagonists attenuate the withdrawal syndrome from barbital. Psychopharmacol. 113, 521-526.
12. Germany, A., Villar, M., Quijada, L., Contreras, E., 1990. Influence of adenosine analogs on morphine tolerance and dependence in mice. Cell. Molec. Biol. 36, 409-414.
13. Golembiowska, K., White, T.D., Sawynok, J., 1996. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307, 157-162.
14. Imaizumi, M., Miyazaki, S., Onodera, K., 1994. Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice. Meth. Find Exp. Clin. Pharmacol. 16, 717-721.
15. Jiang, N., Kowaluk, E.A., Lee, C., Mazdiyasni, H., Chopp, M., 1997. Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur. J. Pharmacol. 320, 131-137.
16. 3H] CGS 21680 to rat brain using autoradiography. Neuropharmacol. 34, 393-403.
17. Kaplan, G.B., Leite-Morris, K.A., 1997. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res. 763, 215-220.
18. Kaplan, G.B., Sears, M.T., 1996. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology 123, 64-70.
19. 1 receptors in morphine dependence. Brain Res. 657, 347-350.
20. Kaplan, G.B., Leite-Morris, K.A., Sethi, R.K., McClelland, E.G., 1998. Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Res. 788, 104-110.
21. Keil, G.J., Delander, G.E., 1994. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271, 37-46.
22. Kowaluk, E.A., Bannon, A., Gunther, K., Kohlhaas, K., Lynch, J., Jarvis, M.F., 1996. The effects of adenosine kinase (AK) inhibitors on acute thermal nociception. Soc. Neurosci. Abstr. 21, 1568.
23. Lloyd, H.G.E., Fredholm, B.B., 1995. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int. 26, 387-395.
24. Meghji, P., 1991. Adenosine production and metabolism. In: Stone, T.W. (Ed.), Adenosine in the Nervous System. Academic Press, San Diego, pp. 25-42.
25. Murai, T., Koshikawa, N., Kanayama, T., Takada, K., Tomiyama, K., Kobayashi, M., 1994. Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261, 65-71.
26. Nestler, E.J., 1997. Molecular mechanisms of opiate and cocaine addiction. Curr. Opinion Neurobiol. 7, 713-719.
27. Parkinson, F.E., Geiger, J.D., 1996. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells. J. Pharmacol. Exp. Ther. 277, 1397-1401.
28. Poon, A., Sawynok, J., 1995. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur. J. Pharmacol. 286, 177-184.
29. 1-receptors on rat locus coeruleus neurones. Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 225-231.
30. 1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677, 193-203.
31. Salem, A., Hope, W., 1997. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 57, 671-679.
32. Snyder, S.H., 1997. Knockouts anxious for new therapy. Nature 388, 624-625.
33. Stoner, G.R., Skirboll, L.R., Werkman, S., Hommer, D.W., 1988. Preferential effects of caffeine on limbic and cortical dopamine systems. Biol. Psychiatry 23, 761-768.
34. Terwilliger, R.Z., Johnson, D.B., Sevarino, K.A., Crain, S.M., Nestler, E.J., 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110.
35. Watson, W.P., Little, H.J., 1995. Identification of distinct components, with different time courses, of the changes in response to convulsive stimuli during ethanol withdrawal. J. Pharmacol. Exp. Ther. 272, 876-884.
36. White, T.D., 1996. Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur. J. Pharmacol. 303, 27-38.
37. Wu, Y., Mercuri, N.B., Johnson, S.W., 1995. Presynaptic inhibition of gamma-aminobutyric acid B-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 273, 576-581.
38. Zhang, G.E., Franklin, P.H., Murray, T.F., 1993. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264, 1415-1424.
39. Zimring, S.T., Miller, L.P., Babb, M.J., Hill, G.M., DaRe, J., Ramirex-Weinhouse, M.M., Ugarkar, B.G., Gruber, H.E., Foster, A.C., Wiesner, J.B., 1995. Adenosine kinase inhibitors exert anticonvulsant activity in rats and mice. Soc. Neurosci. Abst. 21, 366.